These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8894745

  • 1. Intravenous immunoglobulin therapy for refractory myositis.
    Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S.
    Intern Med; 1996 Aug; 35(8):663-7. PubMed ID: 8894745
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P.
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [Abstract] [Full Text] [Related]

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, Godeau P, Herson S.
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [Abstract] [Full Text] [Related]

  • 4. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
    Dalakas MC.
    Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
    [Abstract] [Full Text] [Related]

  • 5. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P, Herson S.
    Rev Med Interne; 1999 Dec; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [Abstract] [Full Text] [Related]

  • 6. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I.
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [Abstract] [Full Text] [Related]

  • 7. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
    Wang DX, Shu XM, Tian XL, Chen F, Zu N, Ma L, Wang GC.
    Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797
    [Abstract] [Full Text] [Related]

  • 8. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P.
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
    Quick A, Tandan R.
    Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
    [Abstract] [Full Text] [Related]

  • 10. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P, Herson S.
    Ann Med Interne (Paris); 1993 Jun; 144(8):521-5. PubMed ID: 8179241
    [Abstract] [Full Text] [Related]

  • 11. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T, Michel BA, Neidhart M, Wassmer P, Neidl K, Fehr K, Wagenhäuser FJ.
    Schweiz Med Wochenschr; 1992 Sep 26; 122(39):1458-65. PubMed ID: 1411405
    [Abstract] [Full Text] [Related]

  • 12. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC.
    J Clin Immunol; 1995 Nov 26; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [Abstract] [Full Text] [Related]

  • 13. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S.
    Arthritis Rheum; 2002 Feb 26; 46(2):467-74. PubMed ID: 11840450
    [Abstract] [Full Text] [Related]

  • 14. [Current therapy for polymyositis and dermatomyositis].
    Chérin P.
    Rev Med Interne; 2008 Jun 26; 29 Spec No 2():9-14. PubMed ID: 18927983
    [Abstract] [Full Text] [Related]

  • 15. Are intravenous immunoglobulin infusions beneficial in the treatment of inflammatory myopathies?
    Sakane T.
    Intern Med; 1996 Aug 26; 35(8):598-9. PubMed ID: 8894731
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.
    Wada J, Shintani N, Kikutani K, Nakae T, Yamauchi T, Takechi K.
    Clin Exp Immunol; 2001 May 26; 124(2):282-9. PubMed ID: 11422206
    [Abstract] [Full Text] [Related]

  • 17. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, Ducrotte P, Cherin P.
    Arthritis Care Res (Hoboken); 2010 Dec 26; 62(12):1748-55. PubMed ID: 20722047
    [Abstract] [Full Text] [Related]

  • 18. Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients.
    Danieli MG, Verga JU, Mezzanotte C, Terrenato I, Svegliati S, Bilo MB, Moroncini G.
    Front Immunol; 2021 Dec 26; 12():805705. PubMed ID: 35111165
    [Abstract] [Full Text] [Related]

  • 19. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.
    Ann Rheum Dis; 2007 Oct 26; 66(10):1276-83. PubMed ID: 17277004
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.
    Hoff LS, de Souza FHC, Miossi R, Shinjo SK.
    Rheumatology (Oxford); 2022 Apr 11; 61(4):1579-1588. PubMed ID: 34302454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.